![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/4045 | (2006.01) |
A61P 25/00 | (2018.01) | ||
A61P 25/18 | (2006.01) | ||
C07D 209/16 | (2013.01) | ||
A61K 9/2009 | (2013.01) | ||
A61P 25/22 | (2006.01) | ||
A61P 25/24 | (2006.01) | ||
A61K 9/2013 | (2013.01) | ||
A61K 9/2027 | (2013.01) | ||
A61P 25/30 | (2006.01) | ||
C07D 209/16 | (2006.01) | ||
A61K 9/2059 | (2013.01) | ||
A61P 25/00 | (2006.01) | ||
A61K 9/485 | (2013.01) | ||
A61K 9/20 | (2006.01) | ||
A61K 9/4858 | (2013.01) | ||
A61K 9/48 | (2006.01) | ||
A61K 9/4866 | (2013.01) | ||
A61K 45/06 | (2006.01) | ||
A61K 31/4045 | (2013.01) | ||
A61K 45/06 | (2013.01) | ||
A61P 25/18 | (2018.01) | ||
A61P 25/22 | (2018.01) | ||
A61P 25/24 | (2018.01) | ||
A61P 25/30 | (2018.01) |
(11) | Number of the document | 3902541 |
(13) | Kind of document | T |
(96) | European patent application number | 21720509.5 |
Date of filing the European patent application | 2021-04-23 | |
(97) | Date of publication of the European application | 2021-11-03 |
(45) | Date of publication and mention of the grant of the patent | 2022-09-14 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2021/060750 |
Date | 2021-04-23 |
(87) | Number | WO 2021/116503 |
Date | 2021-06-17 |
(30) | Number | Date | Country code |
202008303 | 2020-06-02 | GB | |
PCT/EP2020/065244 | 2020-06-02 | WO | |
202016890664 | 2020-06-02 | US | |
202018950 | 2020-12-01 | GB | |
202017108679 | 2020-12-01 | US | |
202018955 | 2020-12-01 | GB | |
202017108938 | 2020-12-01 | US | |
202103981 | 2021-03-22 | GB | |
202117208583 | 2021-03-22 | US |
(72) |
RANDS, Peter , GB
BENWAY, Tiffanie , GB
JOEL, Zelah , GB
LAYZELL, Marie , GB
JAMES, Ellen , GB
|
(73) |
Small Pharma Ltd ,
6-8 Bonhill Street, London EC2A 4BX,
GB
|
(54) | THERAPEUTIC COMPOSITIONS COMPRISING DEUTERATED OR PARTIALLY DEUTERATED N,N-DIMETHYLTRYPTAMINE COMPOUNDS |
THERAPEUTIC COMPOSITIONS COMPRISING DEUTERATED OR PARTIALLY DEUTERATED N,N-DIMETHYLTRYPTAMINE COMPOUNDS |